Progressive multifocal leukoencephalopathy in HIV-1 infection.
about
Progressive multifocal leukoencephalopathy: current treatment options and future perspectivesProgressive multifocal leukoencephalopathy: clinical and molecular aspectsProgressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapiesIlluminating viral infections in the nervous systemStructure-Function Analysis of the Human JC Polyomavirus Establishes the LSTc Pentasaccharide as a Functional Receptor MotifNatalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent RegistryThe trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications.Progressive multifocal leukoencephalopathy presenting as IRIS in an AIDS patient. A case report and literature review.Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review.Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).Unmasking of PML by HAART: unusual clinical features and the role of IRISImmune Reconstitution Inflammatory Syndrome Unmasking or Worsening AIDS-Related Progressive Multifocal Leukoencephalopathy: A Literature ReviewProgressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.Update on opportunistic infections in the era of effective antiretroviral therapyRole of N-linked glycosylation of the 5-HT2A receptor in JC virus infection.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theBrain magnetic resonance imaging screening is not useful for HIV-1-infected patients without neurological symptomsOutcome and survival of asymptomatic PML in natalizumab-treated MS patients.Polyomavirus JC in the context of immunosuppression: a series of adaptive, DNA replication-driven recombination events in the development of progressive multifocal leukoencephalopathy.Rapidly progressive cerebellar ataxia in West WalesCD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolutionFrom Clinical Presentation to the Outcome: the Natural History of PML in a Portuguese Population of HIV Infected Patients.Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity.Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus.Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritisBK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients.Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy.Natalizumab therapy for multiple sclerosisDiagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathySusac's syndrome as HIV-associated immune reconstitution inflammatory syndromeImmune surveillance and response to JC virus infection and PML.Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV.Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab.Management of the immune reconstitution inflammatory syndrome.A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JCV testing.Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review.Maraviroc Failed to Control Progressive Multifocal Leukoencephalopathy-Associated IRIS in a Patient with Advanced HIV Infection.High prevalence of the simultaneous excretion of polyomaviruses JC and BK in the urine of HIV-infected patients without neurological symptoms in São Paulo, Brazil.Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.
P2860
Q26776236-5A101912-2D94-4151-A281-7BD62A55C655Q26858968-A27DAB45-28D1-4592-ABC9-A0BD025B4A10Q27028025-52DAFCCF-3A63-4B11-B692-BB1163BCAC6EQ27310280-DFDDCC52-5A46-4DB7-9917-736FEA955AC3Q27665095-CD59306A-9892-4B88-8363-2150461826B2Q28555138-FE2D1D10-85E6-4C15-A6BC-D3A4ED7E529FQ30617802-CF08222A-49E6-4C9A-96A8-E4479C1FDC58Q30655539-F47BFD76-376D-44DC-A709-F4D6852A36E6Q30778800-C6D5859F-78A1-411D-8422-92436F5C3EFBQ33605681-1120B02E-1E0E-423D-A2EB-47EC9CA7F5DEQ33672408-F20A13BE-4DFA-4C56-8227-1743E106CF8BQ33715659-613577F2-052A-4F8A-A86A-A95E44F64125Q33893285-19866231-7255-408F-B565-F4B89424DCBCQ33933507-EC803260-3D86-4E4E-8832-AA31299B8E0BQ34085853-C11145BB-4D06-44AF-861E-61224CE34140Q34120884-3B25C64B-2ABB-45CF-8B6D-1C7ED4CF2B29Q34212799-87E6BE88-F5A7-4EEA-A1D6-18BBFEA1516CQ34267308-02866D23-CCF4-4192-ADAE-5CC432E03832Q34562841-A98459B2-34C4-417F-AA58-E68864240036Q34729712-3E358786-FF11-44F5-8FA9-16C713F5D2D4Q35050193-3736D39E-CEA3-4B0F-8B53-606866231876Q35121645-D40ED2C3-7474-41D1-B8F0-9D40A064C9C4Q35355938-6513524D-3AE5-48DF-87B6-0283A8D4A510Q35838586-22A44999-080F-4BB8-A597-6E59E8F32E8FQ35931809-D53D6323-3FDC-4647-903A-6C1DF7CC028FQ36190565-001E43EA-D33C-420B-A47F-653AD46ADC56Q36202667-C20D0E5D-68D9-4FF2-82D7-3624CAEDBD7DQ36549104-445413C5-970E-4E2F-A6FE-299C60E958EDQ36568666-1EEEE95F-64F0-49F2-971C-C8A1E6EA4109Q36942417-60051C32-953D-4D31-AC29-199D8D344075Q37154022-9E5352E5-2C20-4FE6-B990-311C6509F9C1Q37678580-C02F2CE2-310C-46F2-8F24-BB9A2BA80950Q37830174-D399F653-EBD9-4D19-B209-61634FF2C4F7Q37982013-2D4B44C9-0C47-4EDB-B774-B7A1875D2872Q38023242-747998E9-1BE1-4554-8F3F-F4A7E91B89C3Q38068499-0DD8D406-3091-4273-BD3B-A623156306A9Q38414352-362867A1-58FF-4FF3-96E3-4925CBE8015BQ39059090-D04F3E79-99EB-4400-81AC-F761A2AD1EDAQ39292862-0FEE5E95-30EC-40B0-AB1A-C1AA4C139173Q39391443-196F6088-1EDC-4705-A65E-1DC91CE72FBA
P2860
Progressive multifocal leukoencephalopathy in HIV-1 infection.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Progressive multifocal leukoencephalopathy in HIV-1 infection.
@ast
Progressive multifocal leukoencephalopathy in HIV-1 infection.
@en
type
label
Progressive multifocal leukoencephalopathy in HIV-1 infection.
@ast
Progressive multifocal leukoencephalopathy in HIV-1 infection.
@en
prefLabel
Progressive multifocal leukoencephalopathy in HIV-1 infection.
@ast
Progressive multifocal leukoencephalopathy in HIV-1 infection.
@en
P2093
P2860
P1476
Progressive multifocal leukoencephalopathy in HIV-1 infection.
@en
P2093
Igor J Koralnik
Jose M Miro
Paola Cinque
Richard W Price
Simonetta Gerevini
P2860
P304
P356
10.1016/S1473-3099(09)70226-9
P577
2009-10-01T00:00:00Z